🇺🇸 FDA
Patent

US 10399963

Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

granted A61PA61P1/02A61P1/04

Quick answer

US patent 10399963 (Substituted benzofuranyl and benzoxazolyl compounds and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Karyopharm Therapeutics Inc.
Grant date
Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18